Twitter is planning to make its first acquisition in India by acquiring Bangalore-based Frrole, a big data startup that sifts through half a billion Twitter posts every month to offer insights about users, vr-zone states.
Started by Amarpreet Kalkat in 2011, Frrole is a social media platform driven by data intelligence. In April 2012, the company launched a Twitter-based news discovery site (news.frrole. com) for consumers.
It is a newspaper that gets its feeds from Twitter. Frrole sorts through these millions of tweets, filters them out into categories and makes up its news for the day.
Following its IPO, acquiring a platform like Frrole would be ideal for Twitter as it can provide better insights when it comes to how users are engaging with a brand.
Frrole has expanded to include more than 55 cities in India, the US, the UK, Canada, Australia and Singapore. Frrole mobile apps, launched early this year, have already seen more than 5,000 downloads.
Recently, the startup extended its offering to enterprises, targeting the media and entertainment industry. It is one of the startups from the 2013 winter batch at Microsoft Ventures Accelerator in India.
Twitter acquired the mobile ad network MoPub for $300 Mn. It also acquired Lucky Sort, a data visualization start-up in May and is looking at companies like Zoomdata and Roambi, which make data visualizations interactive on mobile devices along with RadiomOne.
Twitter comes fourth by number of deals, with Facebook, Google and Groupon beating it, according to PrivCo data.
A new crop of enterprise software start-ups in India is promising to translate mountains of digital data into practical business insights in real time.
In this space, recently, Facebook is also looking to acquire Bangalore-based Little Eye Labs.
Xander group is investing R300 Cr into a project being developed by Bangalore based Nitesh Estate, BS states. The project is focused on the retail segment across a prime 8-acre land in Koramangala, a retail and commercial hub in Bangalore, the land for which was acquired for R380 Cr.
French pharmaceutical company, Sanofi has invested R90 Cr in Apollo Sugar Clinics Limited, the diabetes focused healthcare unit of Apollo Hospitals. The investment is being routed through Sanofi-Synthelabo India by a combination of primary and secondary infusion.